Paper33995336
Whole-Killed Blood-Stage Vaccine: Is It Worthwhile to Further Develop It to Control Malaria?
Cai J and 5 others. Front Microbiol, 2021. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Whole-Killed Blood-Stage Vaccine: Is It Worthwhile to Further Develop It to Control Malaria? Papers, record 33995336. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33995336
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Whole-Killed Blood-Stage Vaccine: Is It Worthwhile to Further Develop It to Control Malaria?
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References101
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28953967 | Malaria-induced interferon-γ drives the expansion of Tbethi atypical memory B cells. | PLoS Pathog | 2017 | https://conductscience.org/library/papers/28953967 | PubMed |
| 2 | 20816843 | Plasmodium immunomics. | Int J Parasitol | 2011 | https://conductscience.org/library/papers/20816843 | PubMed |
| 3 | 19246182 | Mechanism of action of clinically approved adjuvants. | Curr Opin Immunol | 2009 | https://conductscience.org/library/papers/19246182 | PubMed |
| 4 | 26428458 | Large screen approaches to identify novel malaria vaccine candidates. | Vaccine | 2015 | https://conductscience.org/library/papers/26428458 | PubMed |
| 5 | 20098724 | The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis. | PLoS Med | 2010 | https://conductscience.org/library/papers/20098724 | PubMed |
| 6 | 15784594 | Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria. | Infect Immun | 2005 | https://conductscience.org/library/papers/15784594 | PubMed |
| 7 | 27903741 | Whole-Killed Blood-Stage Vaccine-Induced Immunity Suppresses the Development of Malaria Parasites in Mosquitoes. | J Immunol | 2017 | https://conductscience.org/library/papers/27903741 | PubMed |
| 8 | 25913272 | Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. | Lancet | 2015 | https://conductscience.org/library/papers/25913272 | PubMed |
| 9 | 20114028 | Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9. | Cell Host Microbe | 2010 | https://conductscience.org/library/papers/20114028 | PubMed |
| 10 | 30323025 | Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites. | Infect Immun | 2019 | https://conductscience.org/library/papers/30323025 | PubMed |
| 11 | 24029408 | First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers. | Vaccine | 2013 | https://conductscience.org/library/papers/24029408 | PubMed |
| 12 | 20628205 | Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in mice. | J Clin Invest | 2010 | https://conductscience.org/library/papers/20628205 | PubMed |
| 13 | 23136909 | A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. | N Engl J Med | 2012 | https://conductscience.org/library/papers/23136909 | PubMed |
| 14 | 30038217 | Cytotoxic CD8+ T cells recognize and kill Plasmodium vivax-infected reticulocytes. | Nat Med | 2018 | https://conductscience.org/library/papers/30038217 | PubMed |
| 15 | 23929949 | Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. | Science | 2013 | https://conductscience.org/library/papers/23929949 | PubMed |
| 16 | 6057225 | Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. | Nature | 1967 | https://conductscience.org/library/papers/6057225 | PubMed |
| 17 | 30962400 | Transmission-Blocking Vaccines: Old Friends and New Prospects. | Infect Immun | 2019 | https://conductscience.org/library/papers/30962400 | PubMed |
| 18 | 21514227 | A whole parasite vaccine to control the blood stages of Plasmodium: the case for lateral thinking. | Trends Parasitol | 2011 | https://conductscience.org/library/papers/21514227 | PubMed |
| 19 | 22484134 | Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. | Lancet | 2012 | https://conductscience.org/library/papers/22484134 | PubMed |
| 20 | 20637696 | Changes in the burden of malaria in sub-Saharan Africa. | Lancet Infect Dis | 2010 | https://conductscience.org/library/papers/20637696 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41893813 | Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41893813 | PubMed |
| 40563989 | Malaria Vaccines and Global Equity: A Scoping Review of Current Progress and Future Directions. | Biomedicines | 2025 | https://conductscience.org/library/papers/40563989 | PubMed |
| 39847577 | Malaria: Factors affecting disease severity, immune evasion mechanisms, and reversal of immune inhibition to enhance vaccine efficacy. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/39847577 | PubMed |
| 39695728 | Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials. | Malar J | 2024 | https://conductscience.org/library/papers/39695728 | PubMed |
| 37764974 | Alternative and Complementary Approaches to Consider for Effective Babesia Vaccine Development. | Pathogens | 2023 | https://conductscience.org/library/papers/37764974 | PubMed |
| 36993981 | Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children. | Front Immunol | 2023 | https://conductscience.org/library/papers/36993981 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33995336
GET https://conductscience.org/api/papers/v1/33995336/references?page=2